Completed PHASE2 INTERVENTIONAL 2-arm NCT04571619

HOPE Consortium Trial to Reduce Pain and Opioid Use in Hemodialysis (HOPE)

A Randomized Clinical Trial to Evaluate Non-Pharmacologic and Pharmacologic Approaches for Reducing Pain and Opioid Use Among Patients Treated With Maintenance Hemodialysis

Sponsor: Dallas VA Medical Center

Conditions Chronic Pain End Stage Renal Disease Opioid Dependence

Interventions Buprenorphine Pain Coping Skills Training (PCST)

Updated 14 times since 2020 Last updated: Jan 7, 2025 Started: Jan 3, 2021 Primary completion: Dec 21, 2023 Completion: May 31, 2024

This information is for research purposes only and is not medical advice. Consult a healthcare provider before making any medical decision.

This PHASE2 trial investigates Chronic Pain and End Stage Renal Disease and is currently completed. Dallas VA Medical Center leads this study, which shows 14 recorded versions since 2021 — indicating substantial longitudinal coverage. The change history captured here reflects the iterative nature of clinical trial conduct.

Status Flow

Change History

14 versions recorded

Feb 2025 — Present [monthly]

Completed PHASE2
Sep 2024 — Feb 2025 [monthly]

Completed PHASE2
Jul 2024 — Sep 2024 [monthly]

Completed PHASE2

Status: Active Not Recruiting → Completed
Apr 2024 — Jul 2024 [monthly]

Active Not Recruiting PHASE2
Dec 2023 — Apr 2024 [monthly]

Active Not Recruiting PHASE2

▶ Show 9 earlier versions

Aug 2023 — Dec 2023 [monthly]

Active Not Recruiting PHASE2
Jun 2023 — Aug 2023 [monthly]

Active Not Recruiting PHASE2

Status: Recruiting → Active Not Recruiting
Nov 2022 — Jun 2023 [monthly]

Recruiting PHASE2
Mar 2022 — Nov 2022 [monthly]

Recruiting PHASE2
Sep 2021 — Mar 2022 [monthly]

Recruiting PHASE2
May 2021 — Sep 2021 [monthly]

Recruiting PHASE2
Feb 2021 — May 2021 [monthly]

Recruiting PHASE2

Status: Not Yet Recruiting → Recruiting
Jan 2021 — Feb 2021 [monthly]

Not Yet Recruiting PHASE2
Oct 2020 — Jan 2021 [monthly]

Not Yet Recruiting PHASE2

First recorded

Eligibility Summary

No eligibility information available.

Contact Information

Sponsor contact:

Dallas VA Medical Center
Durham VA Health Care System
Hennepin Health Care
Massachusetts General Hospital
National Institute of Diabetes and Digestive and Kidney Diseases (NIDDK)
New York University
Rogosin Institute
University of Illinois at Chicago
University of New Mexico
University of Pennsylvania
University of Pittsburgh
University of Washington
VA New York Harbor Healthcare System
VA Portland Healthcare System
Vanderbilt University Medical Center
West Haven VA Medical Center
West Virginia University
Yale University

Data source: National Institute of Diabetes and Digestive and Kidney Diseases (NIDDK)

For direct contact, visit the study record on ClinicalTrials.gov .

Study Locations

Albuquerque, United States , Boston, United States , Chicago, United States , Dallas, United States , Durham, United States , Minneapolis, United States , Morgantown, United States , Nashville, United States , New York, United States , Philadelphia, United States and 4 more locations